In clinical trial recruitment, there is often an ‘elephant in the room’; unpredictability. A critical part of what we do is to therefore make the unpredictable more predictable for our clients- they trust us to take the reins with this.  We uncover the risks that are approaching- even multiple years ahead. How are we able… Continue reading Making the Unpredictable More Predictable in Patient Recruitment

In our last couple of blogs, we’ve been looking at the relationship between Advocacy and Pharma – especially the growing impact it has. So what can we expect to see over the next year from these collaborations?  We might sound like a broken record here, but there is so much opportunity left on the table… Continue reading Advocacy and Pharma Collaborations: What’s Next?

As we explored in our previous blog post, Advocacy groups have increasingly been collaborating with the pharmaceutical industry over a wide range of areas, and we expect to see the number and impact of these collaborations to grow over the next few years. One of the major areas of this growth will be in advocacy… Continue reading Working with Advocacy to Address DEI: A Trend Worth Keeping

From where we are sitting, we have a really fortunate vantage point to observe the continued growth of the role of Advocacy groups in clinical research. To us, the past 12 months have been quite exciting in this regard. We’ve seen more and more Pharma partners find new and impactful ways to collaborate with Advocacy,… Continue reading Momentum to Define the Role of Advocacy Groups in Research is Growing – But Why?

It’s no secret that patient retention is one of the many challenges a ClinOps leader and their team faces, as they drive studies to success. This is a battle that is typically taken up once a patient has already enrolled onto a study; we think it can be considered a lot earlier than that.  From… Continue reading Protecting Patient Retention Rates in a Clinical Trial Starts Earlier Than You Think

In our previous blog post, we talked about the impact of clinical trial timeline delays on patient communities and our Pharma partners.  Today we’re covering some of the main delay red flags, and how we problem-solve to protect our clients from facing study delays – typically saving 6-12 months per study. First: what causes timeline… Continue reading The Growing Burden Study Timelines for Our Pharma Partners: How We Spot the Red Flags and Problem-Solve in Real-Time

For our Pharma partners, keeping research timelines on track is just one of countless important items they have to balance. It’s not an industry secret that between 30-80% of clinical trials suffer delays, which impacts research and patients in a number of ways. The knock-on effects cause potential new treatments to take longer to reach… Continue reading The Growing Study Timelines Burden for Our Pharma Partners: What Is the Real Impact?

If I were to summarize 2022 at Leapcure, it would be the year of building foundations that support our growth. This year, our team: This mission solidifies what we have believed for years; that clinical research must focus on incorporating diverse patient voices that allows for the development of novel therapies that serve everyone. We… Continue reading 2022 at Leapcure: Reflections from Leadership

In recent years, the role of advocacy groups in the research space has continued to grow. Benefits for patients, research progress, and advocacy groups themselves, are now widely recognized. Pharma-Advocacy partnerships in clinical research affect much more than what we see. Picture the well-known “iceberg image”. The tip of the iceberg has some of the… Continue reading The Deeper Impact of Advocacy-Pharma Partnerships in Research, for Pharma Leaders

I grew up in a multigenerational home, as is the cultural norm with many Hispanic/Latino families. My grandparents built their home when they migrated to the U.S. from Puerto Rico and as a wedding gift to my aunt, they gifted her half the land. Our 2 houses faced each other and my brothers, cousins, and… Continue reading The Balancing Act of a Caretaker